Barclays upgraded Ypsomed (SIX:YPSN) to “overweight” from “equal weight” and downgraded Gerresheimer (ETR:GXIG) to “underweight” from “equal weight” rating, setting price targets of CHF 343 and €19 ...

The Pakistan Medical Association (PMA) has raised alarm over what it describes as an emerging “man-made epidemic” in Pakistan, warning that the continued circulation of unsafe syringes could worsen ...

Federal health authorities on Thursday ordered strict nationwide enforcement of a ban on conventional disposable syringes and initiated a review of safer alternatives, citing growing concerns over ...

Tjoapack provides primary and secondary packaging services for the pharmaceutical sector.

Discusses Positive Top Line Results From REVEAL-2 Phase III Trial in Chronic Thyroid Eye Disease May 5, 2026 8:00 ...

Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...

Alcami Corporation ("Alcami"), a leading U.S.-based contract development and manufacturing organization (CDMO), today announced it has entered into a definitive agreement to acquire Tjoapack, a ...

Pakistan has emerged as the largest contributor worldwide to the number of people living with hepatitis C, according to the World Health Organization Global Hepatitis Report 2026, raising serious ...

Embecta’s latest earnings call balanced long-term strategic steps with stark near-term pain. Management touted the Owen Mumford acquisition, GLP‑1 partnerships, and solid liquidity, yet the discussion ...

AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...

High-frequency ultrasound platform for preclinical imaging, supporting real-time visualization of small animal anatomy and ...

Pakistan has emerged as the world’s largest hub for hepatitis C infections, according to the World Health Organization (WHO) ...